Published in J Am Coll Cardiol on April 19, 2006
Microvolt T-wave alternans physiological basis, methods of measurement, and clinical utility--consensus guideline by International Society for Holter and Noninvasive Electrocardiology. J Am Coll Cardiol (2011) 3.00
Improved Stratification of Autonomic Regulation for risk prediction in post-infarction patients with preserved left ventricular function (ISAR-Risk). Eur Heart J (2008) 1.37
Prognostic utility of T-wave alternans in a real-world population of patients with left ventricular dysfunction: the PREVENT-SCD study. Clin Res Cardiol (2011) 1.20
Ventricular tachycardia and sudden cardiac death. Mayo Clin Proc (2009) 1.01
Role of substrate and triggers in the genesis of cardiac alternans, from the myocyte to the whole heart: implications for therapy. Circulation (2012) 0.93
Scatter in repolarization timing predicts clinical events in post-myocardial infarction patients. Heart Rhythm (2007) 0.89
Prognostic value of microvolt T-wave alternans in a real-world ICD population. Twente ICD Cohort Studie (TICS). Neth Heart J (2014) 0.87
Mechanisms of arrhythmias and conduction disorders in older adults. Clin Geriatr Med (2012) 0.85
Microvolt T-wave alternans as a predictor of mortality and severe arrhythmias in patients with left-ventricular dysfunction: a systematic review and meta-analysis. BMC Cardiovasc Disord (2009) 0.82
Risk stratification for sudden cardiac death: is there a clinical role for T wave alternans? Heart Rhythm (2009) 0.82
Surface Electrocardiogram Predictors of Sudden Cardiac Arrest. Ochsner J (2016) 0.82
Risk stratification for sudden cardiac death: current approaches and predictive value. Curr Cardiol Rev (2009) 0.82
Microvolt T-wave alternans in end-stage renal disease patients--associations with uremic cardiomyopathy. Clin J Am Soc Nephrol (2010) 0.80
On the estimation of T-wave alternans using the spectral fast fourier transform method. Heart Rhythm (2011) 0.80
Targeted antioxidant treatment decreases cardiac alternans associated with chronic myocardial infarction. Circ Arrhythm Electrophysiol (2014) 0.79
Clinical significance of microvolt T-wave alternans. Herzschrittmacherther Elektrophysiol (2007) 0.78
Current developments in microvolt T-wave alternans. Indian Pacing Electrophysiol J (2006) 0.78
A class of Monte-Carlo-based statistical algorithms for efficient detection of repolarization alternans. IEEE Trans Biomed Eng (2012) 0.77
Usefulness of microvolt T-wave alternans testing in the assessment of all-cause mortality and life-threatening ventricular arrhythmia risk in patients with left ventricular dysfunction. Arch Med Sci (2014) 0.75
Electromuscular incapacitating devices discharge and risk of severe bradycardia. Am J Forensic Med Pathol (2015) 0.75
Tools for risk stratification of sudden cardiac death: a review of the literature in different patient populations. Indian Heart J (2014) 0.75
Suggestions to evaluate whether T-wave alternans is T-wave amplitude dependent. Indian Pacing Electrophysiol J (2009) 0.75
In Silico Investigation into Cellular Mechanisms of Cardiac Alternans in Myocardial Ischemia. Comput Math Methods Med (2016) 0.75
Microvolt T-wave alternans in patients undergoing elective coronary artery bypass grafting: a pilot study. Heart Lung Vessel (2015) 0.75
Can microvolt T-wave alternans predict mortality in patients with ischemic cardiomyopathy? Nat Clin Pract Cardiovasc Med (2006) 0.75
The Effect of Slow Coronary Artery Flow on Microvolt T-Wave Alternans. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2014) 0.75
Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med (2003) 13.29
Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med (2009) 11.51
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54
Delayed time to defibrillation after in-hospital cardiac arrest. N Engl J Med (2008) 8.36
Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med (2006) 8.18
Duration of resuscitation efforts and survival after in-hospital cardiac arrest: an observational study. Lancet (2012) 6.60
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol (2011) 6.35
Does this woman have an acute uncomplicated urinary tract infection? JAMA (2002) 5.74
Trends in survival after in-hospital cardiac arrest. N Engl J Med (2012) 5.67
Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short-term mortality. JAMA (2006) 5.06
Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med (2013) 4.79
National trends in use of computed tomography in the emergency department. Ann Emerg Med (2011) 4.72
Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis. Ann Intern Med (2015) 4.62
Appropriateness of percutaneous coronary intervention. JAMA (2011) 4.33
Reduction in acute myocardial infarction mortality in the United States: risk-standardized mortality rates from 1995-2006. JAMA (2009) 4.24
Safety and efficacy of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 serine protease, SAR236553/REGN727, in patients with primary hypercholesterolemia receiving ongoing stable atorvastatin therapy. J Am Coll Cardiol (2012) 4.13
Health literacy and outcomes among patients with heart failure. JAMA (2011) 4.13
Long-term outcomes in elderly survivors of in-hospital cardiac arrest. N Engl J Med (2013) 3.85
Association between stroke center hospitalization for acute ischemic stroke and mortality. JAMA (2011) 3.68
Do Beta-blockers impact microvolt T-wave alternans testing in patients at risk for ventricular arrhythmias? A meta-analysis. J Cardiovasc Electrophysiol (2010) 3.56
Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis. JACC Cardiovasc Imaging (2010) 3.50
Lack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trial. Circulation (2003) 3.38
Automated external defibrillators and survival after in-hospital cardiac arrest. JAMA (2010) 3.36
Hospital variation in time to defibrillation after in-hospital cardiac arrest. Arch Intern Med (2009) 3.27
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med (2010) 3.27
Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg. Am J Psychiatry (2013) 3.03
Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease. N Engl J Med (2015) 2.97
Stent thrombosis. J Am Coll Cardiol (2010) 2.86
Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation (2009) 2.84
Predictors of survival from perioperative cardiopulmonary arrests: a retrospective analysis of 2,524 events from the Get With The Guidelines-Resuscitation registry. Anesthesiology (2013) 2.83
Percutaneous coronary interventions for non-acute coronary artery disease: a quantitative 20-year synopsis and a network meta-analysis. Lancet (2009) 2.81
Translational Research Investigating Underlying Disparities in Acute Myocardial Infarction Patients' Health Status (TRIUMPH): design and rationale of a prospective multicenter registry. Circ Cardiovasc Qual Outcomes (2011) 2.77
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation (2006) 2.72
A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for Quality. JACC Cardiovasc Interv (2008) 2.69
Racial differences in survival after in-hospital cardiac arrest. JAMA (2009) 2.65
Dosing clopidogrel based on CYP2C19 genotype and the effect on platelet reactivity in patients with stable cardiovascular disease. JAMA (2011) 2.57
Response to ticagrelor in clopidogrel nonresponders and responders and effect of switching therapies: the RESPOND study. Circulation (2010) 2.46
Impact of telemedicine intensive care unit coverage on patient outcomes: a systematic review and meta-analysis. Arch Intern Med (2011) 2.41
Regionalization of care for acute ischemic heart disease: a call for specialized centers. Circulation (2003) 2.35
Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol (2006) 2.34
Health care insurance, financial concerns in accessing care, and delays to hospital presentation in acute myocardial infarction. JAMA (2010) 2.33
Diagnostic blood loss from phlebotomy and hospital-acquired anemia during acute myocardial infarction. Arch Intern Med (2011) 2.29
Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis. J Am Coll Cardiol (2010) 2.26
Does microvolt T-wave alternans testing predict ventricular tachyarrhythmias in patients with ischemic cardiomyopathy and prophylactic defibrillators? The MASTER (Microvolt T Wave Alternans Testing for Risk Stratification of Post-Myocardial Infarction Patients) trial. J Am Coll Cardiol (2008) 2.18
Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus. Circulation (2011) 2.17
Trends in acute reperfusion therapy for ST-segment elevation myocardial infarction from 1999 to 2006: we are getting better but we have got a long way to go. Eur Heart J (2008) 2.16
Improvements in door-to-balloon time in the United States, 2005 to 2010. Circulation (2011) 2.13
Use of medical imaging procedures with ionizing radiation in children: a population-based study. Arch Pediatr Adolesc Med (2011) 2.12
Medicare's public reporting initiative on hospital quality had modest or no impact on mortality from three key conditions. Health Aff (Millwood) (2012) 2.04
Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. JAMA (2006) 2.03
Delayed time to defibrillation after intraoperative and periprocedural cardiac arrest. Anesthesiology (2010) 1.93
Impact of age and medical comorbidity on the effectiveness of implantable cardioverter-defibrillators for primary prevention. Circ Cardiovasc Qual Outcomes (2009) 1.89
Identifying patients hospitalized with heart failure at risk for unfavorable future quality of life. Circ Cardiovasc Qual Outcomes (2011) 1.88
Characteristics of heart failure patients associated with good and poor response to cardiac resynchronization therapy: a PROSPECT (Predictors of Response to CRT) sub-analysis. Eur Heart J (2009) 1.86
Patient health status and costs in heart failure: insights from the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS). Circulation (2009) 1.82
Do physicians examine patients in contact isolation less frequently? A brief report. Am J Infect Control (2003) 1.75
Coronary stent restenosis in patients treated with cilostazol. Circulation (2005) 1.73
Delay from symptom onset to hospital presentation for patients with non-ST-segment elevation myocardial infarction. Arch Intern Med (2010) 1.73
Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction. J Am Coll Cardiol (2013) 1.72
Randomized comparison of everolimus- and paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. J Am Coll Cardiol (2011) 1.69
Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease. Circulation (2007) 1.68
Potential impact of the HIPAA privacy rule on data collection in a registry of patients with acute coronary syndrome. Arch Intern Med (2005) 1.68
The influence of smoking status on the pharmacokinetics and pharmacodynamics of clopidogrel and prasugrel: the PARADOX study. J Am Coll Cardiol (2013) 1.65
Primary percutaneous coronary intervention expansion to hospitals without on-site cardiac surgery in Michigan: a geographic information systems analysis. Am Heart J (2008) 1.65
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv (2012) 1.65
A validated prediction tool for initial survivors of in-hospital cardiac arrest. Arch Intern Med (2012) 1.64
Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention. JAMA (2009) 1.63
Meta-analysis: effects of percutaneous coronary intervention versus medical therapy on angina relief. Ann Intern Med (2010) 1.62
Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery. Am Heart J (2006) 1.62
Safety of carotid artery stenting for symptomatic carotid artery disease: a meta-analysis. Eur Heart J (2007) 1.61
Survival benefit with drug-eluting stents in observational studies: fact or artifact? Circ Cardiovasc Qual Outcomes (2011) 1.59
Factors associated with longer time from symptom onset to hospital presentation for patients with ST-elevation myocardial infarction. Arch Intern Med (2008) 1.59
Hospital variation in transfusion and infection after cardiac surgery: a cohort study. BMC Med (2009) 1.58
Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction. J Am Coll Cardiol (2002) 1.58
National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance. J Am Coll Cardiol (2009) 1.57
Area socioeconomic status and mortality after coronary artery bypass graft surgery: the role of hospital volume. Am Heart J (2007) 1.57
Rescue angioplasty or repeat fibrinolysis after failed fibrinolytic therapy for ST-segment myocardial infarction: a meta-analysis of randomized trials. J Am Coll Cardiol (2007) 1.56
Economic impact of angina after an acute coronary syndrome: insights from the MERLIN-TIMI 36 trial. Circ Cardiovasc Qual Outcomes (2009) 1.56